A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"
about
A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A randomized, double blind, cr ...... nd abdominal obesity. "ARAMIA"
@ast
A randomized, double blind, cr ...... nd abdominal obesity. "ARAMIA"
@en
type
label
A randomized, double blind, cr ...... nd abdominal obesity. "ARAMIA"
@ast
A randomized, double blind, cr ...... nd abdominal obesity. "ARAMIA"
@en
prefLabel
A randomized, double blind, cr ...... nd abdominal obesity. "ARAMIA"
@ast
A randomized, double blind, cr ...... nd abdominal obesity. "ARAMIA"
@en
P2093
P2860
P356
P1433
P1476
A randomized, double blind, cr ...... nd abdominal obesity. "ARAMIA"
@en
P2093
Christian F Rueda-Clausen
Federico A Silva Sieger
Gustavo A Márquez
Lina P Pradilla
Patricio López-Jaramillo
Vicente Lahera
P2860
P2888
P356
10.1186/1745-6215-7-28
P577
2006-09-07T00:00:00Z
P5875
P6179
1015544701